Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss [NA]

View source ↗

Summary

This clinical trial is recruiting to evaluate Yiyuancong for the treatment of sudden sensorineural hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiyuancong

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Sudden Hearing Loss, Sensorineural Hearing Loss | NA | Status: RECRUITING